Market Trends of Europe Lab-on-a-chip and Microarrays (Biochip) Industry
This section covers the major market trends shaping the Europe Biochip Market according to our research experts:
Microarrays are Expected to Exhibit a Significant Growth During the Forecast Period.
Microarrays are expected to show significant growth in the market during the forecast period, owing to the growing burden of morbidity and mortality due to chronic diseases and novel technologies developing in the market.
According to the European Cardiovascular Disease Statistics, 2017, around 45% of all the death is caused due to cardiovascular diseases and almost 37% of deaths in the European Union are due to cardiovascular diseases. Microarrays are capable of profiling lncRNA and mRNA expression in atherosclerotic plaques.
Furthermore, in 2019, Quotient Limited received an approval (CE Mark) for Immunohematology (IH) Microarray for use with its MosaiQ diagnostic platform. Therefore, the aforementioned factors are expected to boost the demand for microarrays in the market over the forecast period.
